# Johnson & Johnson (JNJ) — Q1-2024 Earnings Results

**Report date:** 2024-04-16 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2024

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Reaction Not Available

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.71 | N/A | +2.69% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism about future prospects. They highlighted their commitment to navigating market challenges.

**Key quotes:**

> Management emphasized their focus on innovation and long-term growth.

> They acknowledged challenges in the market but expressed confidence in their product pipeline.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

This earnings report indicates that Johnson & Johnson performed better than expected on EPS, which may reflect strong operational efficiency. However, the lack of revenue data and guidance leaves some uncertainty about future performance. Investors will be looking for more clarity in upcoming reports.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2024_